Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Active Surveillance With or Without a 6 Months Apalutamide Treatment in Low Risk Prostate Cancer: A Phase II Randomized Multicenter Trial

NCT03088124 is registered in ClinicalTrials.gov with Institut Paoli-Calmettes as lead sponsor.

NCT NCT03088124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03088124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Active Surveillance With or Without a 6 Months Apalutamide Treatment in Low Risk Prostate Cancer: A Phase II Randomized Multicenter Trial
Lead sponsor
Institut Paoli-Calmettes
Phase
Phase 2
Overall status
Completed
Start date
April 28, 2017
Completion date
October 8, 2024
Enrollment
93 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

low risk prostate cancer